DR
AVNS icon

Davis Rea’s Avanos Medical AVNS Stock Holding History

Davis Rea’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20
Closed -$1K – 54
2021
Q2 		$1K Buy
+20
New +$827 ﹤0.01% 59

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Davis Rea's AVNS Position: Q3 2021 in Review

Davis Rea sold out of Avanos Medical (AVNS) in Q3 2021, closing a stake of 20 shares — an estimated $1K sold.

Davis Rea first reported a position in AVNS in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2021.

  • Davis Rea reported no remaining Avanos Medical position as of Q3 2021 after selling out during the quarter.
  • Davis Rea sold 20 Avanos Medical shares in Q3 2021, an estimated $1K.
  • Davis Rea first reported a position in Avanos Medical in Q2 2021 and held it in 1 quarter.
  • Davis Rea's Avanos Medical position peaked at $1K in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2021.

Based on Davis Rea's 13F filing for Q3 2021, filed 25 Oct 2021.